Direct to consumer advertising (DTCA) – advertising for prescription drugs – is only allowed in the United States (since 1997, when restrictions were loosened) and New Zealand. Drug companies pay for direct to consumer advertising (more than $4 billion in 2005 (Donohue 2007)) because they believe that it increases prescription rates.